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Abstract
We report the stabilization of the human IgG1 Fc fragment by engineered intradomain disulfide bonds. One of these bonds,
which connects the N-terminus of the CH3 domain with the F-strand, led to an increase of the melting temperature of this
domain by 10uC as compared to the CH3 domain in the context of the wild-type Fc region. Another engineered disulfide
bond, which connects the BC loop of the CH3 domain with the D-strand, resulted in an increase of Tm of 5uC. Combined in
one molecule, both intradomain disulfide bonds led to an increase of the Tm of about 15uC. All of these mutations had no
impact on the thermal stability of the CH2 domain. Importantly, the binding of neonatal Fc receptor was also not influenced
by the mutations. Overall, the stabilized CH3 domains described in this report provide an excellent basic scaffold for the
engineering of Fc fragments for antigen-binding or other desired additional or improved properties. Additionally, we have
introduced the intradomain disulfide bonds into an IgG Fc fragment engineered in C-terminal loops of the CH3 domain for
binding to Her2/neu, and observed an increase of the Tm of the CH3 domain for 7.5uC for CysP4, 15.5uC for CysP2 and 19uC
for the CysP2 and CysP4 disulfide bonds combined in one molecule.
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Introduction
Monoclonal antibodies with high affinity and specificity are now
well established therapeutics and invaluable tools for biological
research. Among them, the IgG class is the most abundant one.
This heterotetrameric protein is composed of two light chains and
two heavy chains. Using proteolytic digestion, the IgG antibody
can be divided into 2 antigen binding fragments (Fabs) and the Fc
fragment. The Fc part itself is composed of two CH2 domains and
two CH3 domains that form a homodimeric region at the C-
terminal end of the antibody molecule. These regions associate
with each other with two disulfide bridges in the hinge region
which is located between the CH1 and CH2 domains and by
strong non-covalent interactions between the two CH3 domains
[1]. Two complex N-linked oligosaccharides are attached to the
antibody through an asparagine residue in the CH2 domain. The
oligosaccharides mediate the contact between the two CH2
domains. The CH2 domains harbour the binding sites for all
effector molecules such as the Fcc receptors as well as complement
factor C1q. At the interface between CH2 and CH3 there is the
binding site for neonatal Fc receptor (FcRn), which mediates the
long half-life of antibodies.
The structure of antibody constant domains is similar to that of
variable domains, consisting of beta-strands connected by loops,
some of which contain short alpha-helical stretches. The
framework is mostly rigid and the loops are comparatively more
flexible, as can be seen from the b-factors of various Fc crystal
structures (e.g. 1HZH.PBD and 1OQO.PDB). In the CH3
domain, the loops at the C-terminal tip of the globular domain
are the sites which are most remote from the effector molecule
binding sites and hence are the most attractive sites for engineering
additional functionalities into the Fc fragment.
Recently, we have shown that it is possible to engineer antigen
binding sites into C-terminal loops connecting beta-strands of
CH3 domains, and that Fc fragments containing such modified
CH3 domains, so-called Fcabs, possess all attractive properties of a
classical IgG, at a size of approximately only 50 kDa [2].
Additionally, the paratopes of these CH3-mediated binding sites
are sterically distinct from the classical Fab-mediated binding sites
and could therefore interact with novel epitopes that are
inaccessible to conventional antibodies or antibody fragments.
The plasticity of the Fc fragment that allows it to serve as a
scaffold and to retain all antibody properties while accommodating
the mutations in the loop regions is based on the fact that an Fc
fragment per se is a very stable protein, with the CH3 domain being
even more stable than the CH2 domain. Additionally, the two
domains are generally believed to be independent from each other
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loops, which are introduced for the purpose of creating an antigen
binding site in the CH3 domain, can lead to a certain loss of
stability of the domain due to novel unfavourable intramolecular
interactions. Mutations leading to an increased stability of the
bovine CH3 domains have been described [5]. In their paper, the
authors argue that ‘‘a stabilised scaffold platform would provide
more room for compromise when mutating for functional
purposes’’. An engineered disulfide bridge in an isolated CH2
domain of human IgG has been described to increase the melting
temperature of this domain by almost 20uC [6], however no data
have been shown on the effects of this disulfide bridge when it is
placed in the context of a complete Fc. A llama single-domain
antibody with an artificial disulfide bond has shown a 10uC higher
midpoint temperature of thermal unfolding than the wild-type
version of the molecule [7].
The Fc proteins described in this report were recombinantly
expressed in the yeast Pichia pastoris. Although yeast glycosylation
has an impact on the structure of CH2 domains and the activation
of effector ligands (reviewed in [8]), the X-ray crystallographic
analysis of Fc in complex with FcRn has revealed an interaction
site at the inter-CH2-CH3 domain region [9,10] that is minimally
affected by the glycosylation status [11]. It has been demonstrated
that the interaction of Fc with immobilized FcRn can best be
modelled as Fc binding to two classes of non-interactive sites on
FcRn, and that the observed affinities are higher when FcRn,
rather than Fc, is immobilized [12,13]. In our present report we
resorted to the above experimental outlay to monitor pH-
dependent binding of Fc fragment to FcRn.
We have succeeded to increase the stability of the CH3 domain
of human IgG1 by the introduction of additional intradomain
disulfide bonds. Results on the thermal stability as well as neonatal
Fc receptor binding properties of Fc fragments carrying single as
well as combined engineered intradomain bonds are presented in
this report. To show that thermal stabilization with the described
disulfide bonds is also applicable to an Fc fragment with a newly
introduced antigen binding site, we describe the effect of each
novel disulfide bond as well as the combination of both in the
model Fcab H10-03-6 which binds specifically to Her2/neu [2].
The antigen binding site has been engineered into this Fc fragment
by modifications in the AB and EF loops of the CH domain, and
has led to a decrease of the thermostability of this protein. We
show in this report that the engineered disulfide bonds work not
only in wild-type Fc but were also successful in reestablishing the
thermostability of Fcab H10-03-6.
Results
Design of engineered human Fc fragments with
additional disulfide bonds in the CH3 domain
We aimed at increasing the stability of the human CH3 domain
in the context of an Fc fragment, in order to increase its tolerance
to mutations in loop regions, which may be introduced at a later
stage with the purpose of creating antigen binding sites in this
unconventional region of the antibody molecule. For this purpose
intradomain disulfide bridges were designed.
Out of 29 disulfide bonds that were predicted by DSDBASE to
be possible in the CH3 domain, we selected 5 that seemed to be
the ones with the highest likelihood of success as judged by visual
examination of the crystal structure of an Fc fragment: Thr350
and Leu441 (CysP1), Pro343 and Ala431 (CysP2), Ser375 and
Phe404 (CysP3), Ser375 and Pro396 (CysP4) and Val348 and
Lys439 (CysP5). All residue numberings in this paper are
according to Kabat [14].Three of these constructs either did not
show increased thermostability (CysP1, CysP5) or led to
aggregation of the recombinant protein (CysP3), and were
consequently not analyzed further,. However 2 of the selected
mutants, CysP2 and CysP4, displayed a significantly higher
thermostability than wild-type Fc and furthermore showed a
wild-type like profile in size exclusion chromatography (HPLC),
indicating a stabilized fold and the absence of aggregation.
In CysP2, the N-terminus of the A strand and the C-terminus of
the F strand are disulfide-bonded while in CysP4 the engineered
disulfide bond connects the BC loop and the D-strand. The
location of the stabilizing disulfide bridges is shown in a 2D
presentation of the secondary structure of the CH3 domain in
Figure 1A and in a 3D cartoon presentation of the Fc fragment in
Figure 1B.
Expression and characterization of human Fc expressed
in P. pastoris
The gene coding for human Fc was cloned in the P. pastoris
expression vector pPICZalphaA, expressed and purified by
Protein A affinity chromatography as described in Materials and
Methods. All the mutants described here readily expressed at high
levels as soluble proteins, similar to wild-type Fc, indicating their
overall fitness. They were soluble in aqueous buffer at a
concentration of up to 5 mg/ml similar to wild-type Fc and had
a dimeric conformation as determined by size exclusion chroma-
tography under native conditions. On SDS-PAGE (see Figure S1),
the proteins run at about 55 kDa, indicating the presence of N-
linked glycosylation at residue Asn297 as expected.
Thermostability of wild-type Fc, CysP2, CysP4 and CysP24
The thermal denaturation of human IgG1-Fc in PBS, pH 7.4
over the temperature range 5–100uC is characterised by two
endothermic transitions, at 65uC and 81.9uC. The first transition
has been described to be reversible as shown by heating up to
75uC, cooling and again heating to 90uC, whereas the second
transition is irreversible. However, beyond 75uC, the CH2
transition also becomes irreversible [4].
To test the thermal stability of Fc fragments expressed in P.
pastoris, both Differential Scanning Calorimetry (DSC) and
temperature-dependent Circular Dichroism (tCD) were used.
The results of these measurements are shown in Figure 2 (DSC)
and Figure 3 (tCD), the thermodynamic parameters of melting of
wild-type and mutated Fc fragments derived from DSC data are
given in Table 1, and the melting temperatures derived from tCD
measurements are given in Table 2. By DSC, the Tm of the CH2
transition of wild-type Fc was at 65uC, which is 4uC lower than
that of Fc expressed in mammalian cells. This can be attributed to
differences in the glycosylation pattern between the two expression
systems. The thermal transition of the wild-type CH3 domain
could be fitted with two non-2-state transitions at 77.8uC and
82.6uC, the first event corresponding likely to the melting of CH3
dimer and the second transition representing the denaturation of
CH3 domains. As measured by CD, the secondary structure of the
Fc fragment at 25uC is populated primarily of beta-strands;
therefore thermal denaturation was followed by tCD at 218 nm.
Unfolding started at 54uC and was completed at 82.5uC. A double
sigmoid model was used to obtain Tm values at 65.2uC and 77.0uC.
In all cases, the three mutants CysP2, CysP4 and CysP24 were
remarkably more stable than wild-type Fc. Notably, 50%
unfolding of the CH3 domains of CysP2, CysP4 and CysP24
mutants occurred at temperatures that were significantly higher
than that of wild-type Fc. In the case of CysP4, the second and the
third transition appeared at temperatures 5uC higher than with
wild-type Fc. The stabilization effect was even more pronounced
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appeared at 9uC higher temperature than with wild-type Fc. The
DSC profile of the Fc fragment CysP24, in which the CysP2 and
CysP4 mutations are combined exhibited the second transition at
92.8uC and the third transition at 97.8uC, which is 15uC above the
ones characteristic for wild-type Fc. Interestingly, in all cases
thermal unfolding of the CH2 domain was reversible up to the
temperature point where melting of the CH3 domain started,
which was probed by annealing scans (Fig. 2 A–D and Table 1). In
both mutants with additional single intradomain cysteine bridges,
the Tm of the CH2 domain was slightly decreased by 1.5uC, and in
the double mutant it was decreased by 4uC.
Far-UV CD-spectra of wild-type Fc, CysP2, CysP4 and CysP24
were identical at 25uC, therefore a wavelength of 218 nm was
chosen for all proteins to evaluate thermal unfolding by CD
measurement. Thermal denaturation curves could be fitted with a
double sigmoid model to obtain the Tm values, which have shown
the same trend in stabilization as the data obtained from DSC
measurements (Table 2).
Mass spectrometric analysis
In order to show the presence of the correct disulfide bonds, as
well as the absence of incorrect ones, mass spectrometric analysis
was performed with samples CysP2 and CysP4. From the
comparative analysis of the reduced and the non-reduced peptide-
sample, a number of disulfide-bonded di-peptide masses were
identified. Based on the MS/MS data of the respective reduced
peptide masses, the amino-acid sequences of these peptides were
determined. Subsequently, the theoretical masses of all possible
combinations for the consequential hypothetical cysteine-linked di-
peptides were calculated using the following formula:
MzH ½ 
z
peptide1z MzH ½ 
z
peptide2{ ncysteinesz1

|1:008amu~ MzH ½ 
z
di{peptide
The XICs of the hypothetical masses allowed the identification of
the di-peptides which were actually present in the samples.
Both samples, CysP2 and CysP4, exhibited doubly and triply
charged ions of the mass 2602.19 amu, which corresponds to the
homo-di-peptide EFTC*PPC*PAPEL, linked by two disulfide
bonds, which is derived from the hinge region of the Fc (see Figure
S2A for CysP2 and Figure S2B for CysP4 data). Furthermore, in
both samples doubly, triply and fourfold charged ions of the
mass 3075.66 amu were found, which reflects the di-peptide
resulting from the disulfide bond between the peptide ISRT-
PEVTC*VVVD ( MzH ½ 
z~1417:74) and YKC*KVSNKAL-
PAPIE ( MzH ½ 
z~1661:91), which corresponds to the native
disulfide bond in the CH2 domain (see Figure S2A).
In contrast to CysP2, where neither of these ions were
detected, CysP4 yielded ion masses confirming the disulfide bonds
between the peptides derived from the engineered disulfide bond
in CysP4, VKGFYPC*D ( MzH ½ 
z~928:42) and YKTTPC*VL
( MzH ½ 
z~924:49). Furthermore, the peptides derived from
the native disulfide bond in the CH3 domain, FSC*SVM-
HEALHNHYTQKSLSLSPGK ( MzH ½ 
z~2801:35) and TC*L
( MzH ½ 
z~336:16) were detected. In turn, however, the masses
corresponding to the engineered disulfide bond between the
peptide KTISKAKGQC*REPQV ( MzH ½ 
z~1672:92) and
HEC*LHNHYTQKSLSLSPGK ( MzH ½ 
z~2179:07) were ex-
Figure 1. Graphical presentation of secondary and tertiary structure of the CH3 domain and of an Fc fragment, and location of
engineered disulfide bonds. A: 2D-presentation (‘‘Collier de perles’’ [32]) of the secondary structure of the CH3 domain. The residues that were
mutated to Cysteine to form the engineered disulfide bonds are indicated in green (CysP2) and red (CysP4). Native disulfide bond residues are
indicated in yellow. B: 3D cartoon presentation (created using the PyMOL Molecular Graphics System, Version 1.3, Schro ¨dinger, LLC) of the human
IgG1 Fc fragment (Protein Data Bank (http://www.pdb.org/) accession 1OQO) with the positions that were mutated to create the engineered disulfide
bonds indicated in green and red as in Figure 1A. The native disulfide bonds are shown in yellow.
doi:10.1371/journal.pone.0030083.g001
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PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30083Figure 2. Thermograms of wild-type and disulfide bond stabilized Fc mutants obtained with DSC measurements. A: wild-type Fc, B:
FcCysP2, C: FcCysP4, D: FcCysP24, E: overlay of all 5 proteins. For each protein the point of reversibility of melting of CH2 domain was determined
which is shown as a dashed line in the inset graphs.
doi:10.1371/journal.pone.0030083.g002
Figure 3. Thermal unfolding curves of disulfide bond stabilized Fc-mutants obtained from tCD-measurements. Experiments were
carried out at a protein concentration of 570 mg/ml in PBS at 218 nm using a 1-mm cell.
doi:10.1371/journal.pone.0030083.g003
IgG Fc Stabilised by Intradomain Disulfide Bonds
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30083clusively detected in the sample CysP2. However, no ions
confirming the native CH3 disulfide bond in CysP2 disulfide
bond could be detected, which can be interpreted as follows: the
native disulfide bond within the CH3 domain of CysP4 was found
to span between the C-terminal peptide of the amino-acid
sequence FSC*SVMHEALHNHYTQKSLSLSPGK and the
peptide TC*L. The corresponding native disulfide bond within
CysC2 would thus be expected to also link the C-terminal peptide
of CysP2, namely FSC*SVMHEC*LHNHYTQKSLSLSPGK, to
the peptide TC*L. However, due to the presence of the
engineered, second cysteine residue within this CysP2 derived C-
terminal peptide, which was found to be also linked to the peptide
KTISKAKGQC*REPQV, our experimental conditions should
yield a fairly unconventional analyte comprising three S-S-
interlinked peptides (of approx. 4800.3 Da). We were not able to
confidently detect this structure in the course of the present study.
Alternatively, as indicated in Figure S2, pepsin also generates a
shorter C-terminal peptide variant of CysP2, namely HEC*LHN-
HYTQKSLSLSPGK, which was clearly found to be linked to the
peptide KTISKAKGQC*REPQV. This suggests that the native
disulfide bond of the CH3-domain would also give rise to an S-S
link between the two peptic peptides FSC*SVM and TC*L. These
two latter peptides were not detected in our analysis, which can be
explained by the fact that they are rather short and hydrophilic,
and might thus fail to be retained on a conventional C18 column.
However, despite the lack of direct mass-spectrometric evidence
for the formation of the native CH3 S-S in CysP2, we can
confidently assume its native structure because all other cysteines
within the molecule have been assigned to discrete disulfide-bonds
(i.e. applying Ockham’s razor or lex parsimoniae) and, further-
more, unliganded, free cysteine residues within the protein would
lead to misfolding, multimerization or aggregation. As shown
below, neither of this was observed in CD spectral analysis, or size-
exclusion chromatography.
Structural characterisation of CysP2, CysP4 and CysP24
To investigate the effect of the disulfide bonds on the
conformation of the Fc fragments, far- and near- UV CD spectra
were obtained for all mutants. The results are shown in Figure 4A
and 4B respectively. It can be seen that the Fc fragments with
additional disulfide bonds have intact secondary and tertiary
structures that are very similar to the wild-type Fc fragment, with a
characteristic minimum at 218 nm. The far CD spectrum shows a
weak and broad minimum at about 223 nm, a band that is
traditionally attributed to the absorption of alpha helix. However
in a protein with a low a-helix content such as Fc, changes in this
band are indicative of changes in the conformations of aromatic
side-chains [15].
Inthe nearCD-spectrum,themain minimumwasat273 nmand
a second minimum was observed at 293 nm. Near-UVspectra were
similar for all proteins and had similar absolute intensities,
suggesting that the tertiary structures of Fc and its disulfide-
stabilized variants described here may not be significantly different.
By size exclusion chromatography (Figure 5), we have
established that the disulfide-stabilized Fc variants CysP2, CysP4
and CysP24 have identical elution profiles as wild-type Fc. The
result was further corroborated by using various molecular weight
standards. This observation implies that the introduction of novel
disulfide bonds in the human CH3 domain leads to stabilized Fc
variants that have very similar overall structural parameters as
compared to wild-type Fc. The dimer interface is intact and no
signs of aggregation are observed, which could potentially be
caused by mispairing of cysteine residues.
Binding of FcRn to the stabilized Fc mutants
To examine an eventual impact which the newly introduced
cysteine mutations could have on the binding of the Fc variants to
the neonatal Fc receptor (FcRn), this interaction was studied using
Biolayer Interferometry (BLI, ForteBio Octet). Association to
FcRn, the binding site of which maps to the interface between the
CH2 and CH3 domains, was assessed at pH 6.0, whereas the
biologically important dissociation was measured by shifting the
pH to 7.4. None of the mutants show any observable difference to
wild-type Fc (Figure 6).
Stabilization of Her2/neu binding Fcab H10-03-6 with
CysP2 and CysP4
For the Fc fragment H10-03-6, which binds to Her2 with about
70 nM affinity, a decrease in thermal stability comparing to wild-
type Fc has been observed. In this case irreversible thermal
unfolding can be deconvoluted with two transitions, corresponding
to melting of the CH3 domain at 61.6uC and of the CH2 domain
at 65.3uC. Each of the three mutants H10-03-6-CysP2, -CysP4
and -CysP24 was more stable than the parent clone. In the case of
H10-03-6-CysP4, the transitions were still overlapping and by
deconvolution appeared at 62.9uc and 69.0uC. The stabilization in
the case of H10-03-6-CysP2 was more effective as the transitions
appeared at 62.7uC and 77.0uC. The mutant with combined novel
disulfide bridges H10-03-6-CysP24 has shown transitions at
60.0uC and 80.3uC, which is 19uC above the Tm of the CH3
domain of the unmodified H10-03-6 CH3 domain (Figure 7).
Discussion
A wide variety of strategies and methods has been successfully
applied to increase the thermal stability of proteins, including
Table 1. Transition temperatures of melting of wild-type Fc
and Fc fragments with novel disulfide bonds derived from
DSC data.
Temperature (6C) of transition
Point of reversibility
of CH2 unfolding (6C)
1
st 2
nd 3
rd
wild-type Fc 65.9 78.1 82.6 68.5
CysP2 64.0 86.6 92.8 73.0
CysP4 64.1 82.9 87.3 67.5
CysP24 61.0 92.8 97.8 75.0
doi:10.1371/journal.pone.0030083.t001
Table 2. Melting temperatures of wild-type Fc and Fc
fragments with novel disulfide bonds derived from tCD data.
Temperature (6C) of transition
1
st 2
nd
wild-type Fc 65.2 77.0
CysP2 61.0 85.1
CysP4 62.1 80.7
CysP24 58.8 90.4
doi:10.1371/journal.pone.0030083.t002
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[16], rational or computational design [17,18], or statistical
analysis [5,19]. Engineered disulfide bonds have been used for
stabilization of several globular proteins [20], and in particular for
antibody fragments such as variable domains [7,21]. In one
example, it was shown that the introduction of an additional
disulfide bond between strands C9 and D, and C and E, naturally
occurring or engineered in the llama heavy chain variable
domains can significantly increase their stability [22]. In another
example, also a constant domain was stabilized [6]. In this latter
publication, a remarkable positive shift in the Tm of a human
isolated IgG1 CH2 domain was described. However, it remains to
be demonstrated that this stabilized CH2 domain is also suitable as
a module in an Fc or in a complete immunoglobulin.
We have recently shown [2] that antigen-binding sites can be
introduced in C-terminal loops of the CH3 domain of human
IgG1. Experience from selections of antigen-binding Fc fragments
has indicated to us that some of the mutations that may be
introduced in loop regions with the purpose of creating an antigen
binding site can lead to a decrease of thermostability and of the
folding properties of the Fc fragment. With this in mind, we
attempted to develop a generic approach to increase the intrinsic
stability of the CH3 domain in the context of Fc by introduction of
stabilizing intradomain disulfide bridges.
The introduction of the additional disulfide bonds described in
this report has led to a significant increase in thermostability of the
Fc, while leaving all other measured properties unchanged.
Expression characteristics were identical for all proteins studied,
and structural parameters as assessed by size exclusion chroma-
tography as well as far- and near-UV CD measurements were
indistinguishable. Binding to neonatal Fc receptor also remained
unchanged. A slight decrease in the temperature of the first
transition (1.5uC for CysP2 and CysP4, and 4uC for CysP24) was
however observed. It has been proposed that the intensity of the
first heat absorption peak is dependent on melting of the CH2
domain polypeptide, interaction of the CH2 domains and of the
Figure 4. Spectroscopic characterization of disulfide bond stabilized Fc-mutants: (A) far-UV CD spectra and (B) near-UV CD spectra
of stabilized Fc-mutants. The measurements were carried out at a protein concentration of 570 mg/ml in PBS at 25uC.
doi:10.1371/journal.pone.0030083.g004
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proteins have shown identical folding, we cannot attribute
lowering of the Tm to an unfolded CH2 domain. Stabilization of
CH3 dimer, for example due to ‘‘compacting’’ at low pH values,
however can weaken the cis interactions [3]. This could be the
likely cause for the decrease in temperature of the first transition in
the case of Fc fragments that have been stabilized by disulfide
bonds in the CH3 domain.
The binding of FcRn was used as an indicator of correct folding
of the Fc and of the retention of its remarkably long in vivo half-life.
For example, it has been shown for a Pichia expressed scFv-Fc
fusion protein that its half-life was extended to 93 h in mice in
comparison to 3.5 h for a typical stand-alone scFv [24]. No change
in the association process for the ligand in comparison to wild-type
Fc was observed, and binding of FcRn at pH 6.0 and its pH-
dependent release at pH 7.4 was also unaffected. Yeasts of the
genus Pichia in general attach high-mannose structures, most
commonly Man14GlcNAc2 as compared with even longer (over 50
mannose residues) chains in S. cerevisiae proteins [25]. Modified
carbohydrates can influence protein structure primarily in the
proximity of the N-terminal region of the CH2 domain, which
may imply altered reactivity to effector molecules. In contrast,
Figure 5. Size exclusion chromatograms of wild-type Fc and disulfide bond stabilized Fc-mutants monitored at A280.
doi:10.1371/journal.pone.0030083.g005
IgG Fc Stabilised by Intradomain Disulfide Bonds
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30083FcRn which binds mainly to the inter-CH2-CH3 domain region,
in a ratio of one FcRn dimer to one Fc molecule [9,10] is known to
be largely unaffected by the glycosylation status of the Fc [11].
CysP2 (deltaTm 10uC), in which the N-terminus of the A strand
and the C-terminus of the F strand are disulfide-bonded showed a
higher degree of stabilization in the CH3 domain than CysP4
(deltaTm 5uC), in which the BC loop and the D-sheet were
connected. The contribution of disulfide bonds to protein stability
is presumed to be mainly due to loss of conformational entropy in
the unfolded state [26], assuming the enthalpy change is negligible.
According to Pace [27], the entropic loss by a disulfide bond of an
unfolded protein can be estimated using the following equation for
the conformational entropy deltaS:
DS~{2:1{ 3=2 ðÞ RlnN
where N is the number of residues in the loop forming the disulfide
bond. When the naturally occurring disulfide bond in the CH3
domain was reduced experimentally, good agreement between
the theoretical TdeltaS value and the experimentally deter-
mined deltaG difference between reduced and oxidized forms
(24.1 kcal/mol versus 23 kcal/mol) was found [28]. It was
therefore deduced that the majority of the stabilization energy
provided by the disulfide solely stems from its contribution to the
unfolded state, assuming that the difference in the free energy
change between the two forms in the folded state is small.
Although these computations cannot be applied bona fide to the
Fc fragment as described here, due to the irreversibility of the
unfolding of the CH3 domain, it may give a hint as to why a
considerable difference in the degree of stabilization between the
two intradomain disulfide bond constructs is observed: in the case
of CysP4, there are only 20 residues between the two cysteine
Figure 6. BLI analyses of FcRn interaction with wild-type Fc and with disulfide bond stabilized Fc-mutants. Biotinylated FcRn was
immobilized to streptavidin tips. Association of the Fc fragment was observed at pH 6.0 and a sharp dissociation was induced by shifting the pH to
7.4.
doi:10.1371/journal.pone.0030083.g006
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estimated to be 23.2 kcal/mol whereas in the case of CysP2, there
are 85 residues in the loop forming the disulfide bond, yielding an
estimate of 24.5 kcal/mol.
Another interesting observation is that with the increase in Tm of
the denaturation of the CH3 domains, also the Tm of the second
CH3-associated transition has increased. The most common
explanation for this transition is the event of dimer dissociation.
We therefore conclude that the newly introduced disulfide bridges
not only stabilized the conformation of the monomeric CH3
domain but also enhanced the CH3/CH3 homodimer interaction.
This is in accordance with reports that have shown that native
disulfide bond formation in human CH3 domains is critical for
both, stability and dimerization [28], and this data is also sup-
ported by other reports [29,30].
The results presented in this paper have implications for the
development of stabilized Fc fragments which can be used as
stand-alone scaffolds or as parts of whole antibodies. Mutations are
routinely introduced in antibodies in order to enhance their
effector functions or to achieve longer in vivo half-life. Such
mutations may cause destabilizing effects due to slight alterations
in the interaction network of chemical bonds within the protein
domain. Stabilization efforts such as the ones described here can
counteract such unwanted effects and can therefore allow a higher
degree of freedom for mutagenesis.
All stabilizing mutations described here resulted in stabilized
Fc fragments with wild-type like expression properties, display-
ing homodimeric proteins without tendency for aggregation,
which is an important prerequisite for potentially therapeutic
proteins. Importantly, the engineered disulfide bridges also
exerted their stabilizing effects on a model antigen-binding
Fcab selected in our lab. Interestingly, it was possible also in this
case to combine the stabilization effect of both novel disulfide
bonds. Further studies will be performed to investigate whether
higher thermal stability also correlates with greater stability in
vivo.
Figure 7. Thermograms of Her2/neu binding Fcab H10-03-6 and its disulfide bond stabilized derivatives obtained with DSC
measurements.
doi:10.1371/journal.pone.0030083.g007
IgG Fc Stabilised by Intradomain Disulfide Bonds
PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e30083Materials and Methods
Ethics statement
Under Austrian law and under the internal rules of the
University of Natural Resources and Life Sciences, Vienna, the
work described here did not require permission by an ethics
committee. No animal experiments were performed.
The necessary declaration of work involving the use of
genetically modified microorganisms was performed at the
Committee for Biological Safety of the Department of Biotech-
nology, which subsequently did not forbid the described
experiments (declaration number IAM 2007_03).
Design of intradomain disulfide bridges
Positions in the CH3 domain sequence that could be mutated to
cysteine in order to create disulfide bridges were predicted using
DSDBASE [31] (http://caps.ncbs.res.in/dsdbase/dsdbase.html).
1OQO.PDB was used as a structure of the Fc fragment of human
IgG1. The DSDBASE algorithm identifies residue pairs with
Calpha-Calpha distances of less than or equal to 6.5 A ˚ and Cbeta-
Cbeta distances of less than or equal to 4.5 A ˚ and evaluates the
proposed disulfide bridges using limits for the structural param-
eters of the various torsion angles and S-S bond length. For the
monomeric CH3 domain, 29 potentially suitable positions were
found based on these parameters. All proposed disulfide bridges
were evaluated by visual inspection of the crystal structure of the
Fc fragment (1OQO.PDB) and 5 (CysP1–CysP5) were subse-
quently chosen for experimental evaluation.
Expression and purification of the human IgG1 Fc
fragment
The Fc fragment of human IgG1 was cloned in the expression
vector pPICZalphaA (Invitrogen) and transformed to the AOX
locus of Pichia pastoris strain X33 after linearization with SacI. The
amino acid sequence of the human IgG1 Fc fragment is as follows:
EFTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTC-
VVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYN-
STYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEK-
TISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGF-
YPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLT-
VDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
The cloned sequence contained 2 extra amino acid residues (EF)
at the N-terminal site due to the EcoRI site used for cloning. The
threonine at position 3 corresponds to amino acid position 225
according to Kabat EU numbering.
The recombinant protein was expressed in P. pastoris X33 in the
presence of1%methanolandinduction was continued upto5 days.
The supernatant was harvested by centrifugation, loaded onto a
Protein A HP column (GE Healthcare), eluted with 0.1 M glycine,
pH 3.5, and subsequently dialysed against PBS at 4uC. The protein
concentration was determined by UV spectroscopy using an
absorption coefficient at 280 nm of 1.397 for wild-type Fc dimer.
Mutagenesis
Mutagenesis was performed using the QuikChangeH Multi Site-
Directed Mutagenesis Kit (Stratagene), according to the manu-
facturer’s instructions. The primers used are listed in File S1.
Proteolytic degradation of samples and differential
peptide mapping by mass spectrometry
In order to prevent the potential scrambling reactions of
disulfide bonds during the proteolytic degradation, the samples
were digested at acidic pH. For this, 20 mL of the respective Fc
sample (0.5 mg/mL) were adjusted to 1% formic acid final
concentration, by the addition of 20 mL of 2% formic acid in
water, containing 10 mg/mL pepsin (from porcine gastric mucosa,
Sigma-Aldrich). Prior to the digestion at 37uC, over night, the
resulting pH (i.e. approx. pH 2) was briefly checked on pH paper.
The peptic peptide maps were produced by LC-ESI-MS/MS,
using a Dionex Ultimate 3000 LC-system, coupled to a Waters
Q-TOF Ultima equipped with its standard ESI-source. 5 mL
aliquots of the proteolytic digests were directly loaded onto a
BioBasic C18 column (0.326150 mm, 5 m, Thermo) at a flow rate
of 6 mL 60 mM ammonium formate, pH 3.0, per minute, and
separated by developing a linear gradient from 0 to 80% AcCN (in
60 mM ammonium formate, pH 3.0), over 80 minutes, at a flow
rate of 6 mL per minute.
For MS analysis of the peptic peptides, the capillary voltage was
set to 3.2 kV, the cone voltage to 80 V, the source temperature to
100uC and the desolvation temperature to 120uC. Positively
charged ions were recorded in the m/z range from 50 to 2000.
The MS/MS experiments were performed in the data dependant
acquisition mode, automatically selecting the respective ions, as
well as CID energies. MS and MS/MS data were manually
evaluated using the MassLynx 4.0 software.
In order to identify the elution time points of the disulfide-
bonded di-peptides in the peptide maps based on their
susceptibility to reducing conditions, 5 mL aliquots of the peptic
digests were dried in a speed vac, and taken up in 5 mL 100 mM
NH4HCO3, containing 10 mM DTE. The reduction was then
allowed to stand for 30 minutes at 56uC, before the reduced
samples were directly subjected to LC-ESI-MS/MS analysis.
Differential scanning calorimetry
Differential Scanning Calorimetry experiments were performed
using an automated VP-Capillary DSC Microcalorimeter (Micro-
Cal, Northampton, MA), using 5 mM protein solutions, diluted in
PBS at pH 7.4 The heating rate was 1uC/min, and the heating
was performed from 20uC to 110uC. Fitting was performed using
the non-2-state transition mechanism. The highest temperature
that allowed thermal denaturation of the CH2 domain was first
explored using annealing scans, with the first one from 20uC to the
temperature point at which the start of melting of the CH3
domain was observed as indicated by the deconvolution of the
thermogram, followed by cooling of the sample in situ, and a
second scan from 20uC to 110uC. Data were confirmed by
controls runs in which the highest permissible temperature was
exceeded by 1.5uC.
CD spectroscopy
The circular dichroism (CD) spectra were measured on a
Chirascan spectropolarimeter (Applied Photophysics). A 1 mm
path-length quartz cuvette was used for far-UV spectra measure-
ment, and a 10-mm path-length quartz cuvette was used for the
near-UV spectra measurement. The protein concentration was
570 mg/ml, and the buffer used was PBS. The CD spectra of the
buffer solution were subtracted from the sample spectra before
conversion to absolute CD values.
Thermal unfolding was monitored by measurement of temper-
ature-dependent circular dichroism (tCD) on a Chirascan
spectropolarimeter (Applied Photophysics). A 1 mm quartz cuvette
was used at a wavelength of 218 nm. All measurements were
performed form 25 to 98uC with 0.2uC increment at a heating rate
of 1uC/min.
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A Shimadzu LC-20A Prominence system equipped with a diode
array detector and a refractive index detector was used to perform
size-exclusion HPLC with A TSK G3000 SWXL column
(7.8630 mm). The mobile-phase buffer used was PBS, 200 mM
NaCl. Chromatography was conducted with a constant flow-rate
of 1 ml/min. A total of 50 mg protein at about 1 mg/ml were
loaded on the column for analysis.
Biolayer Interferometry
ForteBio Octet was used for observation of the interaction of
disulfide-stabilized Fc mutants with FcRn. Streptavidin-coated tips
(ForteBio) were loaded with biotinylated FcRn at 5 mg/ml. Fc
fragments at a concentration of 4.8 mM were allowed to associate
in PBS, pH 6.0, and dissociation from FcRn was monitored in
PBS, pH 7.4, at 30uC and with shaking at 1000 rpm. Binding of
Fc fragments to an uncoated tip was used as a reference. Data
were analysed with ForteBio Data Analysis package 6.2. In vivo
biotinylated FcRn was refolded from bacterial inclusion bodies
and was a kind gift of Sune Justesen (University of Copenhagen).
Mutagenesis of Her2/neu binding Fcab H10-03-6
Mutagenesis was performed using the QuikChangeH Multi Site-
Directed Mutagenesis Kit (Stratagene), according to the manu-
facturer’s instructions. The primers used are identical to the
primers used for Fc wild-type, except for the mutation S375C, and
are listed in File S1. Modified Fc fragments were cloned, expressed
and purified and thermograms measured by DSC as described
above for wild-type Fc fragments.
Supporting Information
Figure S1 SDS-PAGE of purified wild-type Fc (lane 1), CysP4
(lane 2), CysP2 (lane 3) and CysP24 (lane 4). Molecular weight
standard (lane M).
(TIF)
Figure S2 MS/MS data enabling prediction of disulfide bonds
based on comparative analysis of the reduced and non-reduced
peptide-sample. A: data derived for CysP2, B: data derived for
CysP4.
(TIF)
File S1 Primers used for site directed mutagenesis.
(DOC)
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